• where experts go to learn about FDA
  • Drug Development

    • Petition Seeks FDA’s “Forced Switch” of ALLEGRA and ZYRTEC to OTC StatusMarch 20th, 2007

      On March 12, 2007, Greenberg Traurig submitted a citizen petition to FDA to switch four prescription antihistamine and antihistamine-decongestant drugs from prescription to OTC status.  The four drugs are ALLEGRA (fexofenidine HCl), ALLEGRA D (fexofenidine HCl; pseudoephedrine HCl), ZYRTEC (cetirizine HCl), and ZYRTEC D (cetirizine …

    • Abigail Alliance v. von EschenbachMarch 15th, 2007

      On March 1, 2007, the District of Columbia Circuit Court of Appeals heard an oral argument in Abigail Alliance v. von Eschenbach.  Previously, a divided court of appeals had ruled that where there are no other FDA-approved treatment options, a terminally ill patient’s access to …